Enento Group Oyj
ENENTO GROUP PLC, INVESTOR NEWS 1 FEBRUARY 2021 AT 1.30 P.M. EET
Publishing of Enento Group’s Financial Statement Release 2020
Enento Group Plc will publish its Financial Statement Release 2020 on Friday, 12 February 2021 at 11.00 a.m. EET. The Financial Statement Release will be available on Enento’s investor website https://enento.com/investors/ after publication.
Enento Group will hold a webcast for analysts, investors and media in English on the same day, where CEO Jukka Ruuska and CFO Elina Stråhlman will present the performance and events of the fourth quarter 2020.
Date and time: Friday, 12 February 2021 at 2.00 p.m. EET
You can follow the English webcast and conference call at:
https://cloud.webcast.fi/enento/enento_2021_0212_q4
To participate in the conference call, please dial in using one of the numbers below:
Finland: +358 (0)9 7479 0360
Sweden: +46 (0)8 5033 6573
United Kingdom: +44 (0)330 336 9104
United States, LA: +1 323-701-0223
United States, NY: +1 646-828-8195
The conference ID code: 984174
The presentation material will be available on the company’s investor website at 1.30 p.m. EET and a recording of the webcast later during the day.
ENENTO GROUP PLC
For further information:
Pia Katila
Investor Relations Manager
tel. +358 10 270 7056
Distribution:
Nasdaq Helsinki
Major media
enento.com/investors
Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 420 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2019 was 146 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom